Purine tracts in duplex DNA can bind oligonucleotide strands in a sequence specific manner to form triple-helix structures. Triple-helix forming oligonucleotides (TFOs) targeting supFG1 constructs have previously been shown to be mutagenic raising safety concerns for oligonucleotide-based pharmaceuticals. We have engineered a TFO, TFO27, to target the genomic Hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus to define the mutagenic potential of such structures at genomic DNA. We report that TFO27 was resistant to nuclease degradation and readily binds to its target motif in a cell free system. Contrary to previous studies using the supFG1 reporter construct, TFO27 failed to induce mutation within the genomic HPRT locus. We suggest that it is possible that previous reports of triplex-mediated mutation using the supFG1 reporter construct could be confounded by DNA quadruplex formation. Although the present study indicates that a TFO targeting a genomic locus lacks mutagenic activity, it is unclear if this finding can be generalised to all TFOs and their targets. For the present, we suggest that it is prudent to avoid large purine stretches in oligonucleotide pharmaceutical design to minimise concern regarding off-target genotoxicity.
Introduction
Purine tracts in duplex DNA can bind third oligonucleotide strands in the major groove to form a triple-helix, or triplex, where the interactions are stabilised by Hoogsteen hydrogen bonds (1, 2) . Additionally, guanine-based sequences are capable of folding into DNA quadruplex structures (3) . To the best of our knowledge, a third oligonucleotide strand has not been shown to facilitate quadruplex formation in duplex DNA.
Triplex forming oligonucleotides (TFOs) can be designed to be in the purine motif with an identical sequence and antiparallel orientation relative to the purine target sequence in the duplex. Those in the pyrimidine motif have a complementary sequence and are parallel in orientation relative to the purine target sequence [reviewed in Ref. (1) ].
Using engineered reporter constructs, several studies have reported that such triplex structures can induce mutation (4) (5) (6) (7) . In particular, a 30 nucleotide purine motif TFO targeting a supFG1 based reporter construct was reported to be capable of inducing mutation in the order of 0.27% (13-fold above the spontaneous mutant frequency) (6) . A corresponding 20 nucleotide TFO was also reported to be biologically active, but to a lesser extent (3.7-fold increase). Sequencing mutant supFG1 clones revealed mainly point mutations and some small deletions around the triplex target sequence (6) . Triplex formation, in the supFG1 based system, was also capable of inducing DNA repair activity and producing truncated transcripts.
In accordance with their results, Wang et al. (6) proposed that triplex formation at duplex DNA blocks the progression of a transcription fork triggering gratuitous and error-prone repair. This gratuitous repair would lead to repeated attempts in transcription generating re-iterative repair patches where such hyperactivity may then introduce mutation (8) . Repeated cycles of triplex formation, inhibition of transcription and stimulation of repair may increase the probability of a mutagenic event.
Triplex formation has also been reported to induce recombination between two tandem supF genes (7) . In particular, TFOs that could bind to the triplex target sequence with high affinity and were DNA based were found to be biologically active (7) . Those that were RNA based were found to lack biological activity even if they could bind to the triplex target sequence with high affinity. This variation was proposed to be due to the greater helical distorting ability of DNA-based TFOs which may provoke the repair pathway in an attempt to remove the DNA lesion (9) .
Although antisense oligonucleotides appear to be powerful tools for sequence-specific manipulation of gene expression (10, 11) , the studies described above present a concern for oligonucleotide-based therapies; specifically, they are suggestive that triplex formation at genomic DNA may lead to heritable sequence alterations. Indeed, the European Medicines Agency (EMA) has raised concern as to whether such oligonucleotide-based pharmaceuticals could present with off-target genotoxicity through triplex formation (12) . Furthermore, chemical modifications adopted in oligonucleotide pharmaceutical design to facilitate nuclease resistance, target binding affinity or in vivo distribution may facilitate triplex formation at genomic DNA (11, (13) (14) (15) .
We have therefore examined the hypothesis that triplex formation within the coding region of genomic DNA is mutagenic. To test this, we have engineered a TFO, TFO27, to target the genomic coding region of the hemizygous HPRT locus in human lymphoblastoid TK6 cells. We report that TFO27 can bind to its target motif with high affinity in a cell free system and was resistant to nuclease degradation. In contrast to previous studies employing reporter systems, TFO27 failed to induce mutation at its genomic target. We also report that the previously employed triplex target sequence within the supFG1 reporter has the potential for DNA quadruplex formation in the presence of the targeting oligonucleotide and suggest that this latter property, rather than triplex formation, may be the mechanism whereby the reporter system is mutated.
Materials and methods
All cell culture reagents were obtained from Invitrogen (Paisley, UK) and cell culture consumables from VWR (Leicestershire, UK). All other chemicals/ reagents were obtained from Sigma Aldrich (Poole, UK), unless stated otherwise.
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Oligonucleotides
All oligonucleotides were DNA based and obtained from Sigma Genosys (Haverhill, UK). Those used in mutation studies were chemically modified to contain four terminal phosphorothioate linkages and reverse phase purified. Oligonucleotide sequences are listed in Table I .
Electrophoretic mobility shift assay
The triplex forming ability of oligonucleotides was assessed using a 35 bp duplex containing the HPRT triplex target sequence. The quadruplex forming ability of the supFG1 sequence was assessed using a 40-mer duplex. Duplex DNA was made by annealing complementary oligonucleotides (Table I) in 50 mM sodium chloride at 60°C for 30 min and cooling at room temperature for 60 min. A fixed concentration of duplex DNA (0.2 μM) was incubated with serial dilutions of targeting oligonucleotide (Table I) in triplex binding buffer  [10 mM Tris (pH 7. 2) and 10 mM MgCl2], triplex binding buffer containing 2.5 mM spermidine and 1%w/v sucrose or quadruplex buffer [10 mM Tris (pH 7.2), 0.1 mM MgCl2 and 140 mM KCl] in a 20 µl reaction volume for 3 h at room temperature. Samples were then electrophoresed through a 15% polyacrylamide gel at 70-80 v in 17.8 mM Tris (pH 7.2), 17.8 mM boric acid and 10 mM MgCl2. Gels were stained with 0.5 μg/ml ethidium bromide and visualised and quantitated by densitometry using a Kodak Imaging Station 4000MM.
Cell culture
Human lymphoblastoid TK6 cells were obtained from ATCC (Middlesex, UK). TK6 cells were cultured in RPMI 1640 media supplemented with 10%v/v heat inactivated horse serum, 2 mM l-glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin.
Optimal conditions for transfection of TK6 cells was investigated by incubating 2 µM 6-carboxyfluorescein (6FAM) conjugated TFO27 (6FAM-TFO27) with various amounts of siPORT NeoFX transfection reagent to allow complex formation. Approximately, 1.5 × 10 5 TK6 cells were mixed with the 6FAM-TFO27/siPORT NeoFX transfection complex in triplicate wells of a 96 well plate at 37°C for 4 h. Following this, TK6 cells were pelleted at 200 × g for 5 min, washed twice in phosphate buffered saline (PBS) and then re-suspended in PBS. Fluorescence was quantitated using the PolarStar Galaxy (BMG labtech, UK) with an excitation/emission of 490/520 nm. The cells in each well were counted using the trypan blue exclusion assay to normalise arbituary fluorescence per viable 10 4 cells. The blank in each case was a mock transfection where 6FAM-TFO27 was replaced with water.
For treatment of TK6 cells, oligonucleotides were mixed with the transfection reagent siPORT NeoFX (Applied Biosystems, UK) in a 2:1 ratio [DNA (µg): siPORT NeoFX (µl)] and allowed to stand to allow complex formation. Meanwhile, TK6 cells were counted and 10 × 10 6 cells were aliquoted per treatment and mixed with the oligonucleotide/siPORT complex. Treatments were in triplicate cultures, unless specified. Transfection was allowed to occur for 4 h at 37°C, 5% CO2. TK6 cells were then washed and suspended for culturing overnight. As a positive control, TK6 cells were treated with 5 μg/ml ethyl methanesulphonate (EMS). To measure the spontaneous mutant frequency at each locus, oligonucleotide transfection mixtures were replaced with culture media (Control). Following treatment, TK6 cells were counted daily for 3 days to determine the relative suspension growth (RSG; a measure of cell death and proliferative ability following treatment; 16).On the third day, TK6 cells were plated at 1.6 cells per well in 96 well plates to determine cloning efficiency and 20 000 cells per well in 4 µg/ml trifluorothymidine (TFT) to determine the thymidine kinase (TK) mutant frequency. This cloning efficiency was used to correct the RSG to give the relative total growth (RTG) as a measure of cytotoxicity following treatment. The remaining cells were maintained for further 4 days phenotypic expression. The HPRT mutant frequency was then determined by seeding 20 000 cells per well in 96 well plates in 5 µg/ml 6-thioguanine (6-TG) and cloning efficiency determined by seeding 1.6 cells per well in the absence of 6-TG. Plates were incubated for 14 days at 37°C, 5% CO2 and then colonies were scored. The cloning efficiencies and mutant frequencies were calculated as described by Clements (16) .
Serum stability assay
The serum stability of oligonucleotides was determined as previously described with slight modification (17) . Additionally, the serum stability of TFO27 with canonical phosphodiester linkages was assessed (PO-TFO27). Oligonucleotides were diluted in cell culture media containing 10%v/v horse serum (without heat inactivation) to a final concentration of 10 μM and incubated at 37°C. Aliquots were removed at the selected times. Reactions were terminated by addition of urea-TBE loading buffer (1xTBE [89 mM Tris pH 8.3, 89 mM boric acid and 2 mM EDTA], 7 M urea and 0.1%w/v bromophenol blue) and subsequent freezing at −80°C. Oligonucleotides were resolved on 1.5% agarose gels containing 0.5 μg/ml ethidium bromide at 80 v. Gels were visualised and quantified using the Kodak IS4000MM. Data were analysed using GraphPad prism 5.0 (GraphPad Software, California, USA) by fitting a single exponential decay function relative to zero hour.
Polymerase chain reaction and DNA sequencing
Polymerase chain reactions (PCRs) were performed to amplify a 177 bp region of exon 3 in the HPRT locus which enclosed the TFO27 triplex target sequence. A typical reaction was observed in a 50 μl reaction volume containing 500 ng of TK6 genomic DNA, 200 nM of each forward and reverse exon 3 primer (Table  I) , 200 μM dNTPs, 5 units of Tfi polymerase (Invitrogen, Paisley, UK) and 1xTfi PCR buffer supplemented with 1.5 mM MgCl2. Amplification was performed using a Peltier thermal cycler as follows: Initial denaturation step at 94°C for 4 min, followed by 30 cycles of denaturing at 94°C for 30 s, annealing at 64°C for 30 s and polymerisation at 72°C for 30 s. The final polymerisation step was extended to 7 min. Samples were then stored at 4°C until the time of analysis. Aliquots of PCR products were resolved by electrophoresis through a 1.4% agarose gel containing 0.5 μg/ml ethidium bromide. Gels were visualised using the Kodak IS4000MM. PCR products were extracted and purified for DNA sequencing using the PureLink Quick gel extraction kit (Invitrogen, Paisley, UK), according to manufacturer's protocol. Purified PCR products were diluted and sequenced by Gene Service Ltd (University College London, UK). 
Results
Study design
We have examined the hypothesis that triplex formation, within a genomic coding sequence, can introduce mutation.
Having identified a purine rich tract in exon 3 of the HPRT locus (Gene ID 3251; nucleotides 113-139 of exon 3), we designed a purine motif TFO 27 nucleotides in length to target this sequence (TFO27; Table I ). As a control, we used an oligonucleotide which contained the same base composition as TFO27 but in a random order (SCR27; Table I ). Using the human lymphoblastoid TK6 cell line (hemizygous for the HPRT locus), mutant cells could be detected through cellular resistance to the toxic effects of 6-TG. Non-target specific genotoxicity caused by the presence of the oligonucleotides was informed by screening the mutant frequency at the TK locus through cell resistance to TFT.
TFO27 binds with high affinity to its target motif
In the first instance, it was important to assess the capability of TFO27 to form a triplex at its target motif. For this, we used an electrophoretic mobility shift assay. Duplex DNA encompassing the purine rich tract in exon 3 of the HPRT locus was incubated with serial dilutions of TFO27 or SCR27. Following this, samples were electrophoresed through polyacrylamide gel. Bands of reduced migration relative to duplex are indicative of triplex formation. A typical gel is shown in Figure 1 . In triplex binding buffer, TFO27 bound duplex DNA with high affinity at concentrations as low as 10 −10 M ( Figure 1A ). This result was reproduced in an independent experiment with similar results (data not shown). As expected, SCR27 failed to form triplex structures at concentrations as high as 10 −5 M ( Figure 1B ). These data indicate sequence-specific triplex formation by TFO27 at its target motif in a cell-free system with a dissociation constant (Kd 50 ) in the sub-nanomolar range. Previous studies examining triplex-mediated mutagenesis have incubated target plasmid DNA with TFO in the presence of spermidine (18, 19) . In the presence of 2.5 mM spermidine, we found both TFO27 and SCR27 to be capable of producing bands of reduced migration ( Figure 1C and 1D) . We suggest that this phenomenon is likely to be a result of the DNA aggregating effects of spermidine rather than motif specific triplex formation (20) .
TFO27 failed to induce mutation at the targeted HPRT locus in human lymphoblastoid TK6 cells
Having demonstrated that TFO27 can bind with high affinity to its target motif in a cell-free system, we assessed its ability to induce mutation at the genomic HPRT locus. For this, we employed the HPRT forward mutation assay in human lymphoblastoid TK6 cells. TK6 cells were transfected with oligonucleotide using siPORT NeoFX transfection reagent over 4 h since electroporation stress induces cells to be more susceptible to mutation (21, 22) .
In the first instance, optimum conditions for transfection of TK6 cells was determined using 2 µM fluorescently labelled TFO27 (6FAM-TFO27) incubated with varying amounts of siPORT NeoFX transfection facilitator. The ratio of DNA (µg) to siPORT NeoFX (µL) investigated was 2:1, 1:1, 1:2 and 1:4. Transfection of 6FAM-TFO27 using a DNA:siPORT NeoFX ratio of 2:1 was found to be optimum although this was only marginally greater than a 1:1 transfection but over 4-fold >1:2 or 1:4 transfection ratios (Figure 2) . A similar result was obtained using 1 µM 6FAM-TFO27 with the same DNA to siPORT NeoFX transfection ratios as described above (data not shown). Whilst these data demonstrate that TFO27 entered the TK6 cells it does not determine whether or not the TFOs actually bound to the genomic target sequence in the cell.
Based on these data, TK6 cells were transfected with oligonucleotide using a 2:1 DNA (µg) to siPORT Neo FX transfection reagent (µl) to investigate the genotoxicity of TFO27. TK6 cells were treated with a dose range of TFO27 that spans the concentrations of oligonucleotide employed in previous studies examining triplex-mediated mutagenesis using reporter constructs (6, 23) .
In this study, cytotoxicity following treatment was assessed by the RTG, which accounts for cell death during treatment and subsequent effects on cell growth and cloning ability (16) . Lethal concentrations of TFO were seen at12.2 µM and were therefore not analysable for mutant frequency. A concentration of 9.8 µM TFO resulted in cytotoxicity of 62% and 66% RTG for SCR27 and TFO27, respectively. Given the steep Fig. 1 . Investigating the triplex forming capability of TFO27 and SCR27. A synthetic 35-mer duplex containing the triplex target sequence in exon 3 of the HPRT locus was annealed using oligonucleotides HPRT-S and HPRT-AS (Table I) and incubated with serial dilutions of oligonucleotide in triplex binding buffer (A and B) or triplex binding buffer containing 2.5 mM spermidine and 1%w/v sucrose (C and D). Samples were then electrophoresed through a polyacrylamide gel. In triplex binding buffer, bands of reduced migration are observed with TFO27 at nanomolar concentrations representing triplex formation (A) whereas SCR27 fails to form such structures (B). Triplex formation is also evident with TFO27 (C) in the presence of spermidine. However, SCR27 also appears capable of associating to duplex DNA in a sequence independent manner in the presence of spermidine (D). Marker 'O' is excess oligonucleotide, 'D' is duplex DNA and 'T' is triplex DNA. dose response, a concentration of 9.8 µM was considered to be the highest acceptable concentration under the conditions of this test. Contrary to previous studies using reporter constructs, TFO27 failed to induce a dose-dependent increase in mutants at its genomic target (Table II) . Off-target genotoxicity was assessed at the non-targeted TK locus through cell resistance to TFT. Neither TFO27 nor SCR27 caused an increase in TK mutants at the higher concentrations employed in this study (Table II) . 
TFO27 is not rapidly degraded by nucleases
Oligonucleotides used throughout this study were chemically modified to contain four terminal phosphorothioate linkages to increase nuclease resistance (24) . To validate this, we used a serum stability assay. Additionally, we assessed the serum stability of TFO27 with canonical phophodiester linkages (PO-TFO27). Oligonucleotides were incubated at 37°C in the presence of cell culture media which contained 10% v/v horse serum. Aliquots were removed at several time points up to 24 h and electrophoresed through a 1.5% agarose gel and bands quantified by densitometry. We found TFO27 and SCR27 were resistant to degradation for at least 24 h in cell culture media (Figure 3) . In contrast, PO-TFO27 was found to be significantly degraded in cell culture media within 3 h (Figure 3) . Thus, four terminal phosphorothioate linkages provided nuclease resistance for TFO27 and SCR27.
Human lymphoblastoid TK6 cells contain wild-type HPRT sequence
As described above, we had demonstrated in cell-free experiments that TFO27 could bind to its target motif with high affinity and was protected against nuclease degradation, yet still failed to induce mutation at the HPRT locus. We therefore sequenced the putative TFO27 target sequence in exon 3 of the HPRT locus in human TK6 cells.
Genomic DNA from TK6 cells was used for PCR amplification of a 177 bp stretch encompassing the TFO27 target sequence in exon 3. Products were resolved on agarose gels and extracted for DNA sequencing. Sequencing confirmed that the TK6 cell line used in our studies contained the proposed TFO27 target sequence and therefore the potential for triplex formation (Supplementary Figure 1 , available at Mutagenesis Online).
The supFG1 triplex target motif is capable of DNA quadruplex formation
Reports of triplex-mediated mutagenesis have focused on using the supFG1 based mutation assay (6, 7, 25) . In this system, a 30 base pair purine stretch composed primarily of guanine (23 nt) Fig. 3 . The stability of oligonucleotides in cell culture media. Oligonucleotides, were incubated at 37°C with cell culture media containing 10%v/v horse serum. Aliquots were removed at selected time points. Samples were electrophoresed through a 1.5% agarose gel containing 0.5 μg/ml ethidium bromide. Bands were analysed by densitometry. Intensities are relative to the zero hour. TFO27 and SCR27 modified to contain 4 terminal phosphorothioate linkages at either end appeared to be resistant to nuclease degradation up to 24 h (PS-TFO and PS-SCR). However, TFO27 containing canonical phosphodiester linkages was rapidly degraded within 3 h (PO-TFO). Data represent mean ± SEM of three independent samples. is targeted using a purine motif TFO. On the basis that guanine rich sequences have been implicated in DNA quadruplex formation (26), we aimed to assess the capability of DNA quadruplex formation by the supFG1 triplex target sequence using an EMSA, as described above. In this case, a band of reduced migration relative to the triplex structure is indicative of DNA quadruplex formation.
We report that in triplex binding buffer, the supFG1 target sequence is capable of DNA triplex and quadruplex formation in the presence of the targeting oligonucleotide AG30 ( Figure 4A , Lane 5). Densitometric quantitation of lane 5 ( Figure 4A ) reveals primarily triplex formation (79%) as opposed to quadruplex formation (18%). As a control, we used the same sequence as AG30 and the supFG1 duplex except that four guanine nucleotides were replaced with adenine to confirm the putative guanine nucleotides involved in quadruplex formation (AG30-4MM and supF-4MM, Table I ). In triplex binding buffer ( Figure 4A ), replacing four guanine nucleotides was found to partially attenuate quadruplex formation (6.5%, Lane 2). Repeating the experiments using a quadruplex buffer containing potassium ( Figure 4B) shown to stabilise quadruplex structures (27) , quadruplex formation by AG30 and the wild-type supFG1 target sequence was almost as prevalent as triplex formation (17% versus 27%, respectively; Lane 5). This observation was confirmed in an independent experiment ( Figure 5 ). In the quadruplex buffer ( Figure 4B ), the level of quadruplex formation by AG30-4MM and supF-4MM was about 50% (Lane 2) of the wild-type supFG1 sequence (Lane 5, 9.5% versus 17%). It may be possible that AG30 interacts with the guanine-based target sequence within the supFG1 duplex such that it stabilises or facilitates quadruplex formation. We also found that replacing four guanine residues to interrupt the contiguous run of guanines within AG30 and the supFG1 duplex partially attenuated quadruplex formation.
Discussion
The potential for oligonucleotides to interact with duplex DNA, in a sequence-specific manner with ensuing mutation has engendered concern in regards to oligonucleotide therapy (12) . Oligonucleotides have previously been reported to induce mutation through triple-helix formation and in a process known as targeted nucleotide exchange (6, 7, 24, 28) . In this study, oligonucleotide-mediated mutagenesis via triplex formation at genomic DNA has been exclusively addressed; we have not examined targeted nucleotide exchange.
In contrast to previous reports using engineered reporter systems, our study suggests that a non-conjugated TFO fails to induce mutation at genomic DNA in human TK6 cells in a mutation assay tested up to a toxic concentration (9.8 µM), that was 80% of a lethal concentration (12.2 µM). Despite the lack of genotoxicity by TFO27, we have shown in cell-free studies that the oligonucleotide was capable of binding to its target motif with high affinity and that it was not a substrate for rapid nuclease degradation. Furthermore, we demonstrated that TFO27 entered the cells as a result of the transfection procedure and that the TK6 cells contained the putative HPRT target sequence highlighting the potential for triplex formation. It must also be acknowledged that this study has only tested the mutagenicity of a single TFO at a single genomic locus. Although a further attempt was made to design a TFO to target an additional selectable locus (TK) to support these data presented here, the limited availability of a purine stretch was an impediment to further investigation.
To the best of our knowledge, this is the first report of cytotoxicity coupled to a mutation endpoint for an oligonucleotide. It is crucial to assess the state of cells following treatment, as stressed cells are more susceptible to mutation thereby biasing an experimental endpoint (21, 22, 29) . For this reason, we chose to use a transfection facilitator (more appropriate for therapeutic oligonucleotides) as opposed to electroporation which has been regularly employed when assessing triplex-mediated Fig. 4 . Investigating the quadruplex forming ability of the supFG1 system previously used (6, 7, 25) . Oligonucleotide sequences are listed in Table I . Duplex DNA containing the supFG1 sequence was incubated with targeting oligonucleotide in triplex binding buffer (A) or quadruplex buffer (B). As a control to the wild type supFG1 sequence, four guanine residues were replaced in the target duplex and targeting oligonucleotide (supF-4MM and AG30-4MM, respectively). In figures A and B, lanes 1-3 are 0.2 mutagenesis (4, 5, 30) . Excessive cytotoxicity was not found in our studies using concentrations of the TFO <9.8 µM and thus was not expected to influence the endpoint of the assay. Lepik et al. (31) suggested that electroporation can change the balance of intracellular ions and even damage cellular DNA directly. This may then lead to activation of p53-dependent and independent cell cycle arrest or apoptosis. Indeed, this was found to be the case with mock electroporation which increased the level of p53 and nuclear localisation of the protein; coupling electroporation with carrier DNA augmented this observation further. As p53 can regulate cell cycle checkpoints, apoptosis and DNA repair this may confer an increase in cell susceptibility to triplex-mediated mutagenesis following electroporation and therefore does not necessarily reflect biologically relevant events (32) .
Oligonucleotides used throughout the mutation study were DNA based and chemically modified to contain four terminal phosphorothioate linkages which we found to permit nuclease resistance in contrast to the unmodified counterpart. Additionally, DNA-based oligonucleotides are reported to be more likely to induce mutation by causing a greater helical distortion than those which are RNA based (7, 9) . Despite high affinity binding of TFO27 to its target motif in cell-free experiments, induction of mutants at the targeted genomic HPRT locus was not observed.
It is noteworthy, that we observed the presence of spermidine facilitated sequence independent DNA aggregation of SCR27 in our binding studies. Thus, the conditions employed previously incubating plasmid DNA with a TFO in the presence of spermidine to demonstrate triplex formation with a mutation endpoint should be interpreted with caution if it is to be extrapolated to the genomic context (18, 19) .
It is pertinent to add that the triplex target sequence in the supFG1 based reporter construct previously used (6, 7, 25) has been reported to be a mutagenic hotspot (33) ; in a contiguous run of guanines located in the TFO target sequence, spontaneous small deletions and insertions have been reported to localise upstream (33) , likely due to a polymerase slippage mechanism at this site (34) . We report here that the supFG1 triplex target sequence is also capable of DNA quadruplex formation in the presence of the targeting oligonucleotide. Replacing four guanine residues in the supFG1 duplex and targeting oligonucleotide partially attenuates quadruplex formation at this sequence. A plausible explanation for the partial and not complete reduction of quadruplex formation in the mutant supFG1 construct is that the quadruplex structure may still be capable of folding with four repeating units of two guanine residues, but with reduced efficiency. Additionally, we report that quadruplex formation in the supFG1 sequence is favoured in a potassium buffer. In support of the results presented here, a DNA stretch of 30 bases containing 23 guanines (as is the case in the supFG1 target sequence) is almost 90% likely to form a quadruplex (26) . We suggest that previous oligonucleotide targeting to this mutation hotspot may be facilitating or stabilising the DNA quadruplex structure which may in turn increase the susceptibility of this sequence to mutation. In accordance with previous results (6), DNA quadruplex formation can also result in truncated transcripts and has been implicated in transcriptional regulation and genomic instability (35, 36) .
Similar to this study, Majumdar et al. (4) employed a psoralen conjugated TFO to target an intronic purine rich tract adjacent to exon 5 of the genomic HPRT locus in Chinese hamster ovary cells. The psoralen TFO was electroporated into the cells and UVA treated after 90 min. This UVA treatment caused psoralen to covalently react with both strands of the duplex to generate interstrand cross-links. Following this, HPRT mutant frequencies were reported to be induced to 122 per million cells. Importantly and in agreement with the results obtained here, omitting the UVA treatment or the psoralen conjugation from the TFO resulted in the cessation of mutation. However, mutation caused by the unconjugated TFO in the intronic sequence may not have resulted in a 6-TG resistant phenotype. Here, we have demonstrated that a TFO targeting a genomic coding region is also not capable of inducing mutation above spontaneous mutation rate of this assay. This outcome suggests that unless triplex formation is accompanied with a covalent link to the genomic DNA, i.e. psoralen conjugation, the structure is unlikely to result in mutation.
Previous studies that used retroviral-based vectors as reporters of triplex-mediated mutagenesis, such as the SV40 based supF gene, integrate into the host cell genome at sites that are actively transcribed (37) (38) (39) ; following integration, gene transcription at these sites is increased on average by 2-to 3-fold. These conditions may favour triplex formation by making the target site more accessible for TFO binding by increasing the window of opportunity due to the open chromatin structure at sites that are actively transcribed. The HPRT sequence used in this study may not be as accessible for TFO binding due to the presence of nucleosome core particles which are reported to inhibit triplex formation (40) or mutation is below the detection limit of this assay or the triplex structure is unwound by a progressing DNA helicase (41) . Given these caveats, this study has informed the potential for mutagenicity of a TFO targeted to a genomic locus.
Acknowledging the limitations of this study (a single TFO targeting a single gene), our data support the proposal that the likelihood of mutation at genomic DNA via triplex formation by a therapeutic modality with a significant purine content is limited.
Supplementary data
Supplementary Figure 1 is available at Mutagenesis Online.
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